Clincosm LogoSign in Get a demo

Small Cell Lung Cancer

Showing 26 - 50 of 284
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC

Completed
  • Small Cell Lung Cancer
  • atezolizumab
  • Chalon-sur-Saône, France
  • +1 more
Jan 5, 2023

Sputum DNA Testing for Lung Cancer in China

Recruiting
  • Lung Cancer
  • +15 more
  • Diagnostic Test: Sputum DNA methylation analysis
  • chest CT or pathological examination
  • Guangzhou, Guangdong, China
    Nanfang Hospital of Southern Medccal University
Dec 29, 2022

Small Cell Lung Cancer Trial in Worldwide (Tiragolumab, Atezolizumab, Carboplatin)

Active, not recruiting
  • Small Cell Lung Cancer
  • Lone Tree, Colorado
  • +123 more
Dec 21, 2022

Small Cell Lung Cancer, NSCLC, Squamous, NSCLC, Non-squamous Trial in Worldwide (ladiratuzumab vedotin)

Recruiting
  • Small Cell Lung Cancer
  • +8 more
  • Chandler, Arizona
  • +65 more
Dec 19, 2022

Atezolizumab Under Real-World Conditions in Patients Treated in

Recruiting
  • Urothelial Carcinoma
  • +3 more
  • Buenos Aires, Argentina
  • +322 more
Dec 19, 2022

Small Cell Lung Cancer, Angiogenesis, Chemo Effect Trial (Surufatinib, Irinotecan)

Not yet recruiting
  • Small Cell Lung Cancer
  • +2 more
  • (no location specified)
Nov 27, 2022

TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

Not yet recruiting
  • Lung Cancer, Non-small Cell
  • Small Cell Lung Cancer
    • (no location specified)
    Nov 16, 2022

    Small Cell Lung Cancer Trial in Worldwide (Irinotecan liposome injection, Topotecan)

    Active, not recruiting
    • Small Cell Lung Cancer
    • Denver, Colorado
    • +117 more
    Nov 22, 2022

    Proteomics in Small Cell Lung Cancer

    Not yet recruiting
    • Small Cell Lung Cancer
      • (no location specified)
      Nov 14, 2022

      Small Cell Lung Cancer Trial in Seoul (Durvalumab)

      Active, not recruiting
      • Small Cell Lung Cancer
      • Seongnam-si, Gyeonggi-do, Korea, Republic of
      • +1 more
      Nov 6, 2022

      Small Cell Lung Cancer Trial in Saint Louis (AL8326 low dose group, AL8326 middle dose group, AL8326 high dose group)

      Recruiting
      • Small Cell Lung Cancer
      • AL8326 low dose group
      • +2 more
      • Saint Louis, Missouri
        Siteman cancer center, Washington University
      Nov 1, 2022

      Small Cell Lung Cancer Trial in Worldwide (ADI-PEG 20 (Arginine deiminase pegylated))

      Terminated
      Has Results
      • Small Cell Lung Cancer
      • ADI-PEG 20 (Arginine deiminase pegylated)
      • New York, New York
      • +7 more
      Oct 3, 2022

      MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

      Active, not recruiting
      • MSI-H Colorectal Cancer
      • +30 more
      • Badalona, Barcelona, Spain
      • +9 more
      Oct 24, 2022

      Small Cell Lung Cancer, Platinum-Sensitive Lung Small Cell Carcinoma, Extensive-stage Small-cell Lung Cancer Trial in Bordeaux

      Not yet recruiting
      • Small Cell Lung Cancer
      • +2 more
      • Association of lurbinectedin and durvalumab
      • Association of carboplatin and etoposide
      • Bordeaux, France
        Institut Bergonié
      Oct 5, 2022

      Small Cell Lung Cancer Trial in Worldwide (ABBV-011, Budigalimab)

      Recruiting
      • Small Cell Lung Cancer
      • Birmingham, Alabama
      • +32 more
      Oct 5, 2022

      Cervical Cancer, Colorectal Cancer, Esophageal Cancer Trial (89Zr-DFO-girentuximab)

      Not yet recruiting
      • Cervical Cancer
      • +13 more
      • (no location specified)
      Sep 28, 2022

      Small Cell Lung Cancer Trial in Worldwide (BMS-986012 (anti-fucosyl-GM1), Nivolumab)

      Active, not recruiting
      • Small Cell Lung Cancer
      • BMS-986012 (anti-fucosyl-GM1)
      • Nivolumab
      • New York, New York
      • +15 more
      Sep 28, 2022

      Small Cell Lung Cancer Trial in Italy (Etoposide, Carboplatin, Bevacizumab)

      Active, not recruiting
      • Small Cell Lung Cancer
      • Bologna, Italy
      • +14 more
      Sep 7, 2022

      Clear Cell Renal Cell Cancer, Non-Small-Cell Lung Cancer, Triple Negative Breast Tumors Trial in Worldwide (AZD8701, Durvalumab)

      Recruiting
      • Clear Cell Renal Cell Cancer
      • +8 more
      • La Jolla, California
      • +22 more
      Aug 12, 2022

      Small Cell Lung Cancer, Lung Cancer Trial in Switzerland (Durvalumab, carboplatin, etoposide)

      Recruiting
      • Small Cell Lung Cancer
      • Lung Cancer
      • Aarau, Switzerland
      • +13 more
      Aug 12, 2022

      Merkel Cell Carcinoma, Small Cell Lung Cancer Trial in United States (XmAb18087, XmAb18087 ± Pembrolizumab)

      Completed
      • Merkel Cell Carcinoma
      • Small Cell Lung Cancer
      • XmAb18087
      • XmAb18087 ± Pembrolizumab
      • Duarte, California
      • +6 more
      Aug 8, 2022

      Microsatellite High Cancers, Peritoneal Mesothelioma, Extrapulmonary High Grade Trial in Houston (XmAb20717)

      Recruiting
      • Microsatellite High Cancers
      • +7 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 8, 2022

      Clear-Cell Metastatic Renal Cell Carcinoma, Non Small Cell Lung Cancer Metastatic, Brain Metastases, Adult Trial in Montreal,

      Active, not recruiting
      • Clear-Cell Metastatic Renal Cell Carcinoma
      • +4 more
      • Montreal, Quebec, Canada
      • +3 more
      Aug 2, 2022

      Small Cell Lung Cancer Trial in Worldwide (Tarlatamab, AMG 404)

      Recruiting
      • Small Cell Lung Cancer
      • Chicago, Illinois
      • +13 more
      Jul 27, 2022

      Small Cell Lung Cancer, Uveal Melanoma, Ovarian Clear Cell Carcinoma Trial in United States (PLX2853)

      Completed
      • Small Cell Lung Cancer
      • +7 more
      • Scottsdale, Arizona
      • +4 more
      Jul 20, 2022